Image (4afcb3c7 F5a1 4c46 9955 970ad02fdecb 01)
Darunavir 600 And 800 Mg Tablet
Product Images NDC 69097-244
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Darunavir 600 And 800 Mg (NDC 69097-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
600mg (4afcb3c7 F5a1 4c46 9955 970ad02fdecb 06)
800mg (4afcb3c7 F5a1 4c46 9955 970ad02fdecb 07)
This is a description of Darunavir Tablets, a prescription medication indicated for certain medical conditions. Each film-coated tablet contains Darunavir Hydrale equivalent to 800 mg of Daruravir. It is important to be aware of medicines that should not be taken with Darunavir Tablets. The usual dosage should be determined according to the package insert for full prescribing information. The tablets should be stored at a temperature between 25°C (77°F) and 30°C (88°F), with excursions permitted between 10°C and 15°C (59°F and 10 88°F). The medication should be kept out of reach of children. It is manufactured by Cipla Ltd. in India and distributed by Cipla USA, Inc. The expiration date and lot number will be overprinted during commercial packing.*
Pk Results (Fig 02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
